Tag: Drug Testing]

Poor reproducibility in assay testing for encapsulated suspensions.

April 18, 2025 Admin

Poor reproducibility in assay testing for encapsulated suspensions. Poor reproducibility in assay testing for encapsulated suspensions. Introduction: In the pharmaceutical industry, ensuring the quality and efficacy of drug products is paramount. Encapsulated suspensions, particularly in the form of hard and soft gelatin capsules, present unique challenges in maintaining consistent assay results. Assay testing is critical…

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms

Difficulty in ensuring compliance with bioequivalence requirements for capsules.

April 9, 2025 Admin

Difficulty in ensuring compliance with bioequivalence requirements for capsules. Difficulty in ensuring compliance with bioequivalence requirements for capsules. Introduction: In the pharmaceutical industry, ensuring that generic formulations are bioequivalent to their branded counterparts is crucial. Bioequivalence ensures that a generic drug releases its active ingredient into the bloodstream at the same rate and level as…

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms

Difficulty in ensuring compliance with capsule stability testing guidelines.

April 5, 2025 Admin

Difficulty in ensuring compliance with capsule stability testing guidelines. Difficulty in ensuring compliance with capsule stability testing guidelines. Introduction: In the pharmaceutical industry, ensuring the stability of solid oral dosage forms, particularly capsules, is crucial for maintaining the efficacy, safety, and quality of medications throughout their shelf life. Capsule stability testing serves as a fundamental…

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms